Old Web
English
Sign In
Acemap
>
authorDetail
>
Rosanna K. Ma
Rosanna K. Ma
Cornell University
Biology
Cancer research
Drug development
Fibrolamellar Carcinoma
MEK inhibitor
3
Papers
8
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
DNAJB1-PRKACA in HEK293T cells induces LINC00473 overexpression that depends on PKA signaling
2021
bioRxiv
Stephanie S. Kim
Ina Kycia
Michael Karski
Rosanna K. Ma
Evan A. Bordt
Julian Kwan
Anju Karki
Elle Winter
Ranan G. Aktas
Yuxuan Wu
Andrew Emili
Daniel E. Bauer
Praveen Sethupathy
Khashayar Vakili
Show All
Source
Cite
Save
Citations (0)
Hotspots of aberrant enhancer activity in fibrolamellar carcinoma reveal molecular mechanisms of oncogenesis and intrinsic drug resistance
2020
bioRxiv
Timothy A. Dinh
Ramja Sritharan
F. Donelson Smith
Adam B. Francisco
Rosanna K. Ma
Rodica P. Bunaciu
Matt Kanke
Charles G. Danko
Andrew P. Massa
John D. Scott
Praveen Sethupathy
Show All
Source
Cite
Save
Citations (0)
Hotspots of Aberrant Enhancer Activity in Fibrolamellar Carcinoma Reveal Candidate Oncogenic Pathways and Therapeutic Vulnerabilities.
2020
Cell Reports
Timothy A. Dinh
Ramja Sritharan
F. Donelson Smith
Adam B. Francisco
Rosanna K. Ma
Rodica P. Bunaciu
Matt Kanke
Charles G. Danko
Andrew P. Massa
John D. Scott
Praveen Sethupathy
Show All
Source
Cite
Save
Citations (8)
1
map